Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Acquisition Market Heating Up As Economy “Stagnates” – C&D's Craigie

This article was originally published in The Tan Sheet

Executive Summary

Church & Dwight CEO Jim Craigie says as the economy continues to "stagnate," a crop of new acquisition opportunities will arise in the consumer packaged goods arena.

Church & Dwight CEO Jim Craigie says as the economy continues to "stagnate," a crop of new acquisition opportunities will arise in the consumer packaged goods arena.

In the current economic climate companies are challenged to deliver "decent" earnings-per-share growth organically, Craigie said May 12 at the Goldman Sachs Consumer Products Symposium in New York.

Instead, firms are looking to drive growth by selling under-performing brands or acquiring more promising properties.

"You'll see some stuff from big pharma," he said, adding that firms might "start to rationalize their portfolios and some good businesses could fall out of that."

Craigie also noted some firms are finding they can focus effectively on either pharma or CPG businesses, but not both.

"Big pharma has learned that CPG is a different type of business than theirs and you shouldn't put a big pharma guy running a CPG business, and you shouldn't put a CPG guy running a big pharma business," he said.

In a reference to Johnson & Johnson, he added: "I think our neighbor down in New Jersey has learned that the very hard way."

Since late 2009, J&J has conducted large-scale recalls of OTCs marketed by its McNeil Consumer Healthcare business due to quality control issues. McNeil's manufacturing currently is operating under a consent decree with FDA that followed the agency's inspections of the firm’s facilities (Also see "Under Consent Decree, J&J Delays Full Return Of Recalled OTCs Until 2012" - Pink Sheet, 25 Apr, 2011.).

Also potentially looking to sell brands or businesses are family-owned entities, which may want to exit the market in fear of high tax rates, Craigie suggested.

The executive said C&D "loves buying family businesses" and currently is "sitting on a lot of cash" that could go toward a purchase, but only if the brand for sale is No. 1 or No. 2 in its category.

"Our plants can handle it, our supply chain can handle it, our marketing and sales teams can handle it," Craigie asserted.

C&D's recent acquisitions include the 2010 purchase of the leading U.S. nasal spray brand Simply Saline (Also see "Simply Saline Acquisition Globalizes Church & Dwight's Nasal Hygiene Reach" - Pink Sheet, 17 May, 2010.).

By Eileen Francis

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS105063

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel